Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2013 · 10-Q
Revenue$1.62M$1.62M+23.0% vs Q3 2012 Net Income-$5.26M-$5.26MN/M vs Q3 2012 EPS Diluted-$0.08-$0.08N/M vs Q3 2012 Gross Profit$685,000+12.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$8,050,000N/M Free Cash Flowderived-$8,154,000N/M Margins · derivedGross margin42.4%−4.1 pt vs Q3 2012
Operating margin-523.6%+262.7 pt vs Q3 2012
Net margin-325.4%+530.6 pt vs Q3 2012
ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end